Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Campone, Mario"'
Autor:
Ginzac A; INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, F- 63000, France. angeline.ginzac@clermont.unicancer.fr.; Centre d'Investigation Clinique UMR501, Clermont-Ferrand, F-63000, France. angeline.ginzac@clermont.unicancer.fr.; Département de Recherche Clinique, Délégation Recherche Clinique et Innovation, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France. angeline.ginzac@clermont.unicancer.fr., Molnar I; INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, F- 63000, France.; Centre d'Investigation Clinique UMR501, Clermont-Ferrand, F-63000, France.; Département de Recherche Clinique, Délégation Recherche Clinique et Innovation, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France., Durando X; INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, F- 63000, France.; Centre d'Investigation Clinique UMR501, Clermont-Ferrand, F-63000, France.; Département de Recherche Clinique, Délégation Recherche Clinique et Innovation, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France.; Service d'oncologie médicale, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France., Motte Rouge T; Service d'oncologie médicale, Centre Eugène MARQUIS, Rennes, France., Petit T; Service d'oncologie médicale, Institut de Cancérologie Strasbourg Europe, Strasbourg, France., D'hondt V; Service d'oncologie médicale, Institut du Cancer de Montpellier Val d'Aurelle, Montpellier, France., Campone M; Service d'oncologie médicale, Institut de Cancérologie de l'Ouest, René GAUDUCHEAU, Saint Herblain, France., Bonichon-Lamichhane N; Service d'oncologie médicale et radiothérapie, Clinique Tivoli, Bordeaux, France., Venat Bouvet L; Service d'oncologie médicale, CHU Dupuytren, Limoges, France., Levy C; Service d'oncologie médicale, Centre François BACLESSE, Caen, France., Augereau P; Service d'oncologie médicale, Institut de Cancérologie de l'Ouest, René GAUDUCHEAU, Saint Herblain, France., Pistilli B; Service d'oncologie médicale, Institut Gustave ROUSSY, Villejuif, France., Arsene O; Service d'oncologie médicale, Centre Hospitalier de Blois, Blois, France., Jouannaud C; Service d'oncologie médicale, Institut Jean GODINOT, Reims, France., Nguyen S; Service d'oncologie médicale, Centre Hospitalier de Pau, Pau, France., Cayre A; Service d'anatomopathologie, Centre Jean PERRIN, Clermont-Ferrand, France., Tixier L; Service d'anatomopathologie, Centre Jean PERRIN, Clermont-Ferrand, France., Mahier Ait Oukhatar C; Unicancer, Paris, France., Nabholtz JM; Centre d'oncologie, Université King Saud (Medical City), Riyadh, Arabi Saoudite., Penault-Llorca F; INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, F- 63000, France.; Service d'anatomopathologie, Centre Jean PERRIN, Clermont-Ferrand, France., Mouret-Reynier MA; Service d'oncologie médicale, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Jun; Vol. 205 (2), pp. 267-279. Date of Electronic Publication: 2024 Mar 07.
Autor:
Rugo HS; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. hope.rugo@ucsf.edu.; Department of Medicine (Hematology/Oncology), University of California San Francisco Helen Diller Family Comprehensive Cancer Center, 1825 4th St., 3rd Floor, San Francisco, CA, 94158, USA. hope.rugo@ucsf.edu., Van Poznak CH; University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA., Neven P; University Hospitals Leuven, Louvain, Belgium., Danielewicz I; Szpital Morski Im. PCK, Gdynia, Poland., Lee SC; National University Hospital (S) Pte Ltd, Singapore, Singapore., Campone M; Institut de Cancerologie de l'Ouest, St Herblain, France., Chik JYK; Queen Elizabeth Hospital, Kowloon, Hong Kong., Vega Alonso E; Centro Integral Oncológico Clara Campal, Madrid, Spain., Naume B; Institute of Clinical Medicine, University of Oslo, and Oslo University Hospital, Oslo, Norway., Brain E; Institut Curie - René-Huguenin Hospital, Saint-Cloud, France., Siegel JM; Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, USA., Li R; Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, USA., Uema D; Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, USA., Wagner VJ; Bayer Consumer Care AG, Basel, Switzerland., Coleman RE; Cancer Clinical Trials Centre, University of Sheffield, Weston Park Hospital, Sheffield, UK. r.e.coleman@sheffield.ac.uk.; Department of Oncology and Metabolism, Cancer Clinical Trials Centre, Weston Park Hospital, Broomcross Building, Floor 2, Whitham Road, Sheffield, S10 2SJ, UK. r.e.coleman@sheffield.ac.uk.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Apr; Vol. 204 (2), pp. 249-259. Date of Electronic Publication: 2023 Dec 20.
Autor:
Rassy E; Department of Cancer Medicine, University of Paris Saclay, Gustave Roussy, Villejuif, France., Filleron T; BiostatisticsDepartment, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France., Viansone A; Department of Cancer Medicine, University of Paris Saclay, Gustave Roussy, Villejuif, France., Lacroix-Triki M; Department of Biopathology, University of Paris Saclay, Roussy, Villejuif, France., Rivera S; Department of Radiation Therapy, University of Paris Saclay, Gustave Roussy, Villejuif, France., Desmoulins I; Department of Medical Oncology, Centre Oscar Lambret, Lille, France., Serin D; Department of Medical Oncology, Institut Sainte-Catherine, Avignon, France., Canon JL; Department of Medical Oncology, Grand Hôpital de Charleroi, Charleroi, Belgium., Campone M; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Site René Gauducheau, Site Hospitalier Nord, Saint-Herblain, France., Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Levy C; Department of Medical Oncology, Centre François Baclesse, Caen, France., Cottu P; Department of Medical Oncology, Institut Curie, Paris, France., Petit T; Department of Medical Oncology, Centre Paul Strauss, Strasbourg, France., Eymard JC; Department of Medical Oncology, Institut Godinot, Reims, France., Debled M; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Bachelot T; Department of Medical Oncology, Centre Leon Berard, Lyon, France., Dalenc F; Department of Medical Oncology, Institut Claudius Regaud, Institut Universitaire Cancer Toulouse-Oncopole, Toulouse, France., Roca L; Institut Régional du Cancer de Montpellier, Parc Euromédecine, Montpellier, France., Lemonnier J; R&D UNICANCER, UCBG, Paris, France., Delaloge S; Department of Cancer Medicine, University of Paris Saclay, Gustave Roussy, Villejuif, France., Pistilli B; Department of Cancer Medicine, University of Paris Saclay, Gustave Roussy, Villejuif, France. barbara.pistilli@gustaveroussy.fr.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Jun; Vol. 199 (2), pp. 371-379. Date of Electronic Publication: 2023 Mar 29.
Autor:
Campone M; Western Cancer Institute, Nantes, France. mario.campone@ico.unicancer.fr., De Laurentiis M; Istituto Nazionale Tumori IRCCS 'Fondazione Pascale', Naples, Italy., Zamagni C; IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy., Kudryavcev I; Kaluga Regional Clinical Oncology Center, Kaluga, Russian Federation., Agterof M; St. Antonius Hospital, Utrecht/Nieuwegein, The Netherlands., Brown-Glaberman U; University of New Mexico Cancer Center, Albuquerque, NM, USA., Palácová M; Masaryk Memorial Cancer Institute, Brno, Czech Republic., Chatterjee S; Tata Medical Center, Kolkata, India., Menon-Singh L; Novartis Pharmaceuticals, East Hanover, NJ, USA., Wu J; Novartis Pharmaceuticals, East Hanover, NJ, USA., Martín M; Gregorio Marañón General University Hospital, Madrid, Spain.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2022 May; Vol. 193 (1), pp. 95-103. Date of Electronic Publication: 2022 Feb 25.
Autor:
De Laurentiis M; Division of Breast Medical Oncology, Department of Breast and Thoracic Oncology Director, Istituto Nazionale Tumori IRCCS 'Fondazione Pascale', Napoli, Italy. m.delaurentiis@istitutotumori.na.it., Borstnar S; Institute of Oncology Ljubljana, Ljubljana, Slovenia., Campone M; Western Cancer Institute, Nantes, France., Warner E; Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Bofill JS; Virgen del Rocío University Hospital, Biomedicine Institute, Seville, Spain., Jacot W; Montpellier Cancer Institute, Montpellier, France., Dent S; The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada.; Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA., Martin M; Gregorio Marañón General University Hospital, GEICAM, Universidad Complutense, CIBERONC, Madrid, Spain., Ring A; Royal Marsden Hospital NHS Foundation Trust, Sutton, UK., Cottu P; Curie Institute, Paris, France., Lu J; USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Ciruelos E; University Hospital 12 de Octubre, Clara Campal Comprehensive Cancer Center (HM CIOCC), Madrid, Spain., Azim HA; Faculty of Medicine, Cairo University, Cairo, Egypt., Chatterjee S; Tata Medical Center, Kolkata, India., Zhou K; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Wu J; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Menon-Singh L; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Zamagni C; Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italia.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Jan; Vol. 191 (1), pp. 223-224.
Autor:
De Laurentiis M; Division of Breast Medical Oncology, Department of Breast and Thoracic Oncology Director, Istituto Nazionale Tumori IRCCS 'Fondazione Pascale', Napoli, Italy. m.delaurentiis@istitutotumori.na.it., Borstnar S; Institute of Oncology Ljubljana, Ljubljana, Slovenia., Campone M; Western Cancer Institute, Nantes, France., Warner E; Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Bofill JS; Virgen del Rocío University Hospital, Biomedicine Institute, Seville, Spain., Jacot W; Montpellier Cancer Institute, Montpellier, France., Dent S; The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada.; Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA., Martin M; Gregorio Marañón General University Hospital, GEICAM, Universidad Complutense, CIBERONC, Madrid, Spain., Ring A; Royal Marsden Hospital NHS Foundation Trust, Sutton, UK., Cottu P; Curie Institute, Paris, France., Lu J; USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Ciruelos E; University Hospital 12 de Octubre, Clara Campal Comprehensive Cancer Center (HM CIOCC), Madrid, Spain., Azim HA; Faculty of Medicine, Cairo University, Cairo, Egypt., Chatterjee S; Tata Medical Center, Kolkata, India., Zhou K; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Wu J; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Menon-Singh L; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Zamagni C; Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italia.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Oct; Vol. 189 (3), pp. 689-699. Date of Electronic Publication: 2021 Aug 19.
Autor:
Goetz MP; Department of Oncology, Mayo Clinic, 200 First St. S.W, Rochester, MN, 55905, USA. Goetz.Matthew@mayo.edu., Okera M; Adelaide Cancer Center, Adelaide, Australia., Wildiers H; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Campone M; Institut de Cancerologie de L'Ouest-René Gauducheau, Saint Herblain, France., Grischke EM; Women's Hospital, University Hospital Tübingen, Tübingen, Germany., Manso L; 12 de Octubre University Hospital, Madrid, Spain., André VAM; Eli Lilly and Company, Paris, France., Chouaki N; Eli Lilly and Company, Paris, France., San Antonio B; Eli Lilly and Company, Madrid, Spain., Toi M; Breast Cancer Unit, Kyoto University Hospital, Kyoto University, Kyoto, Japan., Sledge GW Jr; Stanford University School of Medicine, Stanford, CA, USA.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Apr; Vol. 186 (2), pp. 417-428. Date of Electronic Publication: 2021 Jan 03.
Autor:
Verma S; Department of Oncology, Cumming School of Medicine, Tom Baker Cancer Centre, University of Calgary, 1331 29th Street NW, Calgary, AB, T2N 4N2, Canada. DrSunil.Verma@ahs.ca., O'Shaughnessy J; Texas Oncology-Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, and The US Oncology Network, 3410 Worth Street, Suite 400, Dallas, TX, 75246, USA., Burris HA; Drug Development, Sarah Cannon Research Institute, 250 25th Avenue North, Suite 100, Nashville, TN, 37203, USA., Campone M; Medical Oncology, Institut de Cancérologie de l'Ouest/René Gauducheau Centre de Recherche en Cancérologie, Boulevard Jacques Monod, Nantes, 44805, Saint-Herblain, France., Alba E; Medical Oncology Unit, Hospital Universitario Virgen de la Victoria, IBIMA, 29010, Málaga, Spain., Chandiwana D; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA., Dalal AA; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA., Sutradhar S; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA., Monaco M; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA., Janni W; Department of Gynecology, Universitätsklinikum Ulm, Prittwitzstraße 43, 89075, Ulm, Germany.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2018 Aug; Vol. 170 (3), pp. 535-545. Date of Electronic Publication: 2018 Apr 13.
Autor:
Janni W; University of Ulm, Helmholtzstraße 18, 89081, Ulm, Germany. Wolfgang.Janni@uniklinik-ulm.de., Alba E; Hospital Universitario Virgen de la Victoria, IBIMA, Málaga, Spain., Bachelot T; Centre Léon Bérard, Lyon, France., Diab S; Rocky Mountain Cancer Centers, Aurora, CO, USA., Gil-Gil M; Institut Català d'Oncologia, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Beck TJ; Highlands Oncology Group, Fayetteville, AR, USA., Ryvo L; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Lopez R; Hospital Clínico Universitario e Instituto de Investigación Santiago-CIBERONC, A Coruña, Spain., Tsai M; Minnesota Oncology, Minneapolis, MN, USA., Esteva FJ; Perlmutter Cancer Center at New York University Langone Health, New York, NY, USA., Auñón PZ; Hospital Universitario La Paz, Madrid, Spain., Kral Z; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic., Ward P; Oncology Hematology Care, Kenwood, OH, USA., Richards P; Oncology Hematology Associates of Southwest Virginia, Roanoke, VA, USA., Pluard TJ; Saint Luke's Health System, Kansas City, MO, USA., Sutradhar S; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Miller M; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Campone M; Centre René Gauducheau, Institut de Cancérologie de l'Ouest, Saint-Herblain, France.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2018 Jun; Vol. 169 (3), pp. 469-479. Date of Electronic Publication: 2018 Feb 05.
Autor:
du Rusquec P; Medical Oncology Department, Centre René Gauducheau, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France. pauline.durusquec@ico.unicancer.fr., Palpacuer C; Biometrics Department, Centre René Gauducheau, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France., Campion L; Biometrics Department, Centre René Gauducheau, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France., Patsouris A; Medical Oncology Department, Centre Paul Papin, (ICO), Saint-Herblain, France., Augereau P; Medical Oncology Department, Centre Paul Papin, (ICO), Saint-Herblain, France., Gourmelon C; Medical Oncology Department, Centre René Gauducheau, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France., Robert M; Medical Oncology Department, Centre René Gauducheau, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France., Dumas L; Pharmacy Department, Centre René Gauducheau, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France., Caroline F; Pharmacy Department, Centre Paul Papin (ICO), Saint-Herblain, France., Campone M; Medical Oncology Department, Centre René Gauducheau, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France., Frenel JS; Medical Oncology Department, Centre René Gauducheau, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2018 Apr; Vol. 168 (2), pp. 559-566. Date of Electronic Publication: 2017 Dec 15.